ALX Oncology Holdings Inc. - stock earnings
ALXO Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -45.5 million USD | ? USD |
2023Q3 | -51.0 million USD | ? USD |
2023Q2 | -34.2 million USD | ? USD |
2023Q1 | -28.6 million USD | ? USD |
2022Q4 | -30.7 million USD | ? USD |
2022Q3 | -34.0 million USD | ? USD |
2022Q2 | -32.1 million USD | ? USD |
2022Q1 | -24.3 million USD | ? USD |
2021Q4 | -28.4 million USD | ? USD |
2021Q3 | -24.6 million USD | ? USD |
2021Q2 | -16.3 million USD | ? USD |
2021Q1 | -14.2 million USD | ? USD |
2020Q4 | -18.8 million USD | 1 USD |
2020Q3 | -10.2 million USD | ? USD |
2020Q2 | -11.3 million USD | 527000 USD |
2020Q1 | -5.5 million USD | 655000 USD |
2019Q4 | -7.8 million USD | 1.2 million USD |
2019Q3 | -3.0 million USD | 1.3 million USD |
2019Q2 | -4.2 million USD | 1.3 million USD |
2019Q1 | -4.2 million USD | 1.0 million USD |
ALXO Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -160.8 million USD | ? USD |
2022 | -123.5 million USD | ? USD |
2021 | -83.5 million USD | ? USD |
2020 | -45.7 million USD | 1.2 million USD |
2019 | -19.2 million USD | 4.8 million USD |
2018 | -13.7 million USD | 2.1 million USD |
ALXO
Price: $17.10
52 week price:
Earnings Per Share: -3.74 USD
P/E Ratio: -4.38
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 63179
Market Capitalization: 613.4 million